PSMD13 Antibody Blocking peptide
PSMD13 Antibody Blocking peptide
Product Specifications
Product Name Alternative
26S proteasome non-ATPase regulatory subunit 13, 26S proteasome regulatory subunit RPN9, 26S proteasome regulatory subunit S11, 26S proteasome regulatory subunit p405, PSMD13
UniProt
Q9UNM6
Field of Research
Epigenetics
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the N-term region of human PSMD13. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2044130-01 0.1 mL
APC-Linked Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
Sign In for Pricing
View Details MBS2044130-02 0.2 mL
APC-Linked Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
Sign In for Pricing
View Details MBS2044130-03 0.5 mL
APC-Linked Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
Sign In for Pricing
View Details